The lupus drug Benlysta was voted 13-2 to get approval by an advisory panel of the Food and Drug Administration (FDA) this week on Tuesday. This will become the first drug in more than 50 years for the treatment of lupus.

The final date decided for the approval by the FDA is December 3rd and it is under no obligation to stick to the advisory panel’s advice but it usually does so.

This new drug will not act miraculously in treating people suffering from this disease but they will definitely get relief and even let them discontinue the use of other medication with harmful side-effects which they might be taking for the disease.

SLE or systematic lupus erythematous is a chronic condition which surfaces when the immune system of the body starts attacking its own tissues and organs thinking of them as harmful foreign bodies.

The symptoms include fever, joint pain, swelling, sores in the mouth, pain in the chest and even hair loss but different people can get affected with lupus differently and the disease damages internal organs which finally causes death.